LINCOLN
Invest with MTF
Invest Now
Invest in Lincoln Pharmaceuticals with 2.91X leverage
Performance
- Low
- ₹609
- High
- ₹654
- 52 Week Low
- ₹440
- 52 Week High
- ₹696
- Open Price₹645
- Previous Close₹654
- Volume124,293
- 50 DMA₹500.89
- 100 DMA₹508.67
- 200 DMA₹534.47
Investment Returns
- Over 1 Month + 29.3%
- Over 3 Month + 18.61%
- Over 6 Month + 14.91%
- Over 1 Year + 10.95%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.2
- PEG Ratio
- -8.3
- Market Cap Cr
- 1,249
- P/B Ratio
- 1.7
- Average True Range
- 32.7
- EPS
- 43.85
- Dividend Yield
- 0.3
- MACD Signal
- 12.08
- RSI
- 73.65
- MFI
- 93.6
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹623.55
-30.75
(-4.7%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹519.32
- 50 Day
- ₹500.89
- 100 Day
- ₹508.67
- 200 Day
- ₹534.47
Resistance and Support
628.75
- R3 694.10
- R2 674.05
- R1 648.80
- S1 603.50
- S2 583.45
- S3 558.20
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹623 As on 16 February, 2026 | 21:26
The Market Cap of Lincoln Pharmaceuticals is ₹1249 Cr As on 16 February, 2026 | 21:26
The P/E ratio of Lincoln Pharmaceuticals is 14.2 As on 16 February, 2026 | 21:26
The PB ratio of Lincoln Pharmaceuticals is 1.7 As on 16 February, 2026 | 21:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.